Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer

DOI Full Paper Access

53

Citations

19

References

2014

Year

Elizabeth Maunsell, Paul E. Goss, Rowan T. Chlebowski, James N. Ingle, José E. Alés‐Martínez, Gloria E. Sarto, Carol J. Fabian, Pascal Pujol, A. Guarnizo Ruiz, Andrew Cooke,

Journal of Clinical Oncology

Abstract

Exemestane given for prevention has limited negative impact on menopause-specific and health-related QOL in healthy postmenopausal women at risk for breast cancer.

References

	Year	Citations

Page 1